Sernova (SVA) Competitors C$0.23 0.00 (0.00%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades SVA vs. ABCN, EMC, FRX, BCT, IPA, MDNA, SCYB, COM, TH, and NVHShould you be buying Sernova stock or one of its competitors? The main competitors of Sernova include VIVO Cannabis (ABCN), Emblem (EMC), Fennec Pharmaceuticals (FRX), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Medicenna Therapeutics (MDNA), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Theratechnologies (TH), and Novoheart (NVH). These companies are all part of the "biotechnology" industry. Sernova vs. VIVO Cannabis Emblem Fennec Pharmaceuticals BriaCell Therapeutics ImmunoPrecise Antibodies Medicenna Therapeutics Scythian Biosciences 138267 (COM.TO) Theratechnologies Novoheart VIVO Cannabis (CVE:ABCN) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, community ranking, valuation and earnings. Do analysts rate ABCN or SVA? Sernova has a consensus price target of C$1.83, suggesting a potential upside of 697.10%. Given Sernova's stronger consensus rating and higher probable upside, analysts plainly believe Sernova is more favorable than VIVO Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VIVO Cannabis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sernova 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in ABCN or SVA? 0.1% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is ABCN or SVA more profitable? VIVO Cannabis' return on equity of 0.00% beat Sernova's return on equity.Company Net Margins Return on Equity Return on Assets VIVO CannabisN/A N/A N/A Sernova N/A -726.29%-119.26% Does the MarketBeat Community prefer ABCN or SVA? VIVO Cannabis received 117 more outperform votes than Sernova when rated by MarketBeat users. However, 91.67% of users gave Sernova an outperform vote while only 71.91% of users gave VIVO Cannabis an outperform vote. CompanyUnderperformOutperformVIVO CannabisOutperform Votes12871.91% Underperform Votes5028.09% SernovaOutperform Votes1191.67% Underperform Votes18.33% Does the media favor ABCN or SVA? In the previous week, VIVO Cannabis' average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score. Company Overall Sentiment VIVO Cannabis Neutral Sernova Neutral Which has stronger valuation & earnings, ABCN or SVA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVIVO CannabisN/AN/AN/AN/AN/ASernovaN/AN/A-C$38.93M-C$0.13-1.77 SummarySernova beats VIVO Cannabis on 7 of the 10 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Sernova News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SVA vs. The Competition Export to ExcelMetricSernovaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$74.82MC$166.07MC$5.12BC$6.05BDividend Yield7.86%3.64%4.91%5.43%P/E Ratio-1.77114.6691.3426.16Price / SalesN/A17,963.611,117.701,327.99Price / Cash6.1512.7542.6482.04Price / Book-5.758.404.793.07Net Income-C$38.93M-C$20.67MC$120.07MC$294.08M7 Day PerformanceN/A-1.08%-1.90%-2.47%1 Month Performance-2.13%135.79%11.45%-0.78%1 Year Performance-66.18%136.53%30.63%34.57% Sernova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SVASernova1.4631 of 5 starsC$0.23flatC$1.83+697.1%-65.2%C$74.82MN/A-1.771,959Gap DownABCNVIVO CannabisN/AC$1.32+5.6%N/A+0.0%C$256.62MN/A0.00N/AGap UpEMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AFRXFennec PharmaceuticalsN/AC$8.61-0.8%N/A-37.9%C$235.57MC$48.89M86.8010Analyst RevisionNews CoverageBCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080News CoverageGap DownMDNAMedicenna TherapeuticsN/AC$1.71-3.4%N/A+317.1%C$130.70MN/A-4.6620SCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AC$2.95-2.6%N/AN/AC$102.19MN/A0.00N/ATHTheratechnologiesN/AC$2.19+1.9%N/A+23.8%C$100.70MC$82.57M-11.94103News CoverageHigh Trading VolumeNVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/A Related Companies and Tools Related Companies VIVO Cannabis Alternatives Emblem Alternatives Fennec Pharmaceuticals Alternatives BriaCell Therapeutics Alternatives ImmunoPrecise Antibodies Alternatives Medicenna Therapeutics Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Theratechnologies Alternatives Novoheart Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:SVA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
